Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
1
25%
Ph early_phase_1
1
25%
Ph not_applicable
2
50%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD

NCT05723588
completedearly_phase_1

Nicotine Patch Pretreatment for Smoking Cessation in PTSD

NCT00625131
completednot_applicable

Yoga for Men Attempting Smoking Cessation

NCT02055326
completednot_applicable

Smoking Treatment and Anxiety Management Program

NCT01753141

Clinical Trials (4)

Showing 4 of 4 trials
NCT05723588Phase 2

Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD

Recruiting
NCT00625131Early Phase 1

Nicotine Patch Pretreatment for Smoking Cessation in PTSD

Completed
NCT02055326Not Applicable

Yoga for Men Attempting Smoking Cessation

Completed
NCT01753141Not Applicable

Smoking Treatment and Anxiety Management Program

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4